Foster Aaron E. 4

4 · BELLICUM PHARMACEUTICALS, INC · Filed Apr 9, 2020

Insider Transaction Report

Form 4
Period: 2020-04-08
Foster Aaron E.
Sr VP, Head of Research
Transactions
  • Award

    Restricted Stock Units

    2020-04-08+19,51719,517 total
    Common Stock (19,517 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The RSUs vest in full on April 8, 2021.

Documents

1 file
  • 4
    wf-form4_158645783421178.xmlPrimary

    FORM 4